Direct identification of ligand-receptor interactions on living cells and tissues

Frei et al . show that a new tri-functional reagent identifies unknown cell-surface receptors bound by known ligands on living cells. Many cellular responses are triggered by proteins, drugs or pathogens binding to cell-surface receptors, but it can be challenging to identify which receptors are bou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2012-10, Vol.30 (10), p.997-1001
Hauptverfasser: Frei, Andreas P, Jeon, Ock-Youm, Kilcher, Samuel, Moest, Hansjoerg, Henning, Lisa M, Jost, Christian, Plückthun, Andreas, Mercer, Jason, Aebersold, Ruedi, Carreira, Erick M, Wollscheid, Bernd
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Frei et al . show that a new tri-functional reagent identifies unknown cell-surface receptors bound by known ligands on living cells. Many cellular responses are triggered by proteins, drugs or pathogens binding to cell-surface receptors, but it can be challenging to identify which receptors are bound by a given ligand. Here we describe TRICEPS, a chemoproteomic reagent with three moieties—one that binds ligands containing an amino group, a second that binds glycosylated receptors on living cells and a biotin tag for purifying the receptor peptides for identification by quantitative mass spectrometry. We validated this ligand-based, receptor-capture (LRC) technology using insulin, transferrin, apelin, epidermal growth factor, the therapeutic antibody trastuzumab and two DARPins targeting ErbB2. In some cases, we could also determine the approximate ligand-binding sites on the receptors. Using TRICEPS to label intact mature vaccinia viruses, we identified the cell surface proteins AXL, M6PR, DAG1, CSPG4 and CDH13 as binding factors on human cells. This technology enables the identification of receptors for many types of ligands under near-physiological conditions and without the need for genetic manipulations.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2354